ROLE OF DELAYED PHASE TUMOR CONTRAST WASHOUT IN PATIENTS OF HEPATOCELLULAR CARCINOMA ON COMPUTED TOMOGRAPHY

Código QR

ROLE OF DELAYED PHASE TUMOR CONTRAST WASHOUT IN PATIENTS OF HEPATOCELLULAR CARCINOMA ON COMPUTED TOMOGRAPHY

Objective: To evaluate role of delayed phase tumor contrast washout in patients of hepatocellular carcinoma on computed tomography. Study Design: Comparative - cross-sectional study. Place and Duration of Study: Study was conducted in Department of Radiology, Pakistan Institute of Medical Scie...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ayesha Munir, Shahla Zameer
Formato:	article
Lenguaje:	EN
Publicado:	Army Medical College Rawalpindi 2019
Materias:	delayed phase hepatocellular carcinoma multiple detector computed tomography Medicine R Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/463dc1902a1b4c79861803f075be487f
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

DIAGNOSTIC ACCURACY OF CONTRAST ENHANCED COMPUTED TOMOGRAPHY IN DIAGNOSING RENAL CELL CARCINOMA, TAKING HISTOPATHOLOGY AS GOLD STANDARD
por: Ayesha Munir, et al.
Publicado: (2019)

Impact of cone-beam computed tomography with automated feeder detection software on the survival outcome of patients with hepatocellular carcinoma during treatment with conventional transarterial chemoembolization
por: Kittipitch Bannangkoon, et al.
Publicado: (2021)

Design of a High-Energy and High-Resolution detector for X-ray computed tomography
por: Maulin Maëva, et al.
Publicado: (2021)

Diagnostic Accuracy of Delayed Phase Post Contrast Computed Tomographic Images in the Diagnosis of Focal Liver Lesions in Dogs: 69 Cases
por: Silvia Burti, et al.
Publicado: (2021)

DEVELOPMENT AND VALIDATION OF A SOLID-PHASE EXTRACTION GAS CHROMATOGRAPHY-MASS SPECTROMETRY METHOD FOR THE SIMULTANEOUS QUANTIFICATION OF OPIOID DRUGS IN HUMAN WHOLE BLOOD AND PLASMA
por: BRAVO,FELIPE, et al.
Publicado: (2011)

Imaging features of histological subtypes of hepatocellular carcinoma: Implication for LI-RADS
por: Roberto Cannella, et al.
Publicado: (2021)

Corrigendum: Diagnostic Accuracy of Delayed Phase Post Contrast Computed Tomographic Images in the Diagnosis of Focal Liver Lesions in Dogs: 69 Cases
por: Silvia Burti, et al.
Publicado: (2021)

NDRG2 inhibition facilitates angiogenesis of hepatocellular carcinoma
por: Wang Jianlong, et al.
Publicado: (2021)

FORENSIC CASES IN THE NORTH OF CHILE: DETERMINATION OF ANTIDEPRESSANT DRUGS IN HUMAN WHOLE BLOOD
por: BRAVO,FELIPE, et al.
Publicado: (2013)

Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
por: L. V. Bolotina
Publicado: (2020)

Prediction of early recurrence and response to adjuvant Sorafenib for hepatocellular carcinoma after resection
por: Liming Zheng, et al.
Publicado: (2021)

Diabetes mellitus does not influence results of hepatectomy in hepatocellular carcinoma: case control study
por: Yoshihiro Inoue, et al.
Publicado: (2021)

Artificial Intelligent Multi-Modal Point-of-Care System for Predicting Response of Transarterial Chemoembolization in Hepatocellular Carcinoma
por: Zhongqi Sun, et al.
Publicado: (2021)

Prediction of Early Treatment Response to Initial Conventional Transarterial Chemoembolization Therapy for Hepatocellular Carcinoma by Machine-Learning Model Based on Computed Tomography
por: Dong Z, et al.
Publicado: (2021)

Overexpression of PIK3R1 promotes hepatocellular carcinoma progression
por: Ai,Xuejun, et al.
Publicado: (2018)

IMMUNOHISTOCHEMICAL EXPRESSION OF GLYPICAN-3 IN HEPATOCELLULAR CARCINOMA
por: Dr Syed Salman Ali, et al.
Publicado: (2018)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Toofan Datfar, et al.
Publicado: (2021)

Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol
por: Jiang Bo, et al.
Publicado: (2021)

A Dual-Modality MR/PA Imaging Contrast Agent Based on Ultrasmall Biopolymer Nanoparticles for Orthotopic Hepatocellular Carcinoma Imaging
por: Sun J, et al.
Publicado: (2019)

Manuka honey enhanced sensitivity of HepG2, hepatocellular carcinoma cells, for Doxorubicin and induced apoptosis through inhibition of Wnt/β-catenin and ERK1/2
por: Al Refaey,Heba R., et al.
Publicado: (2021)

Hepatocarcinoma con invasión cardiovascular: comunicación de 5 casos y revisión de la literatura
por: Valera M,José M, et al.
Publicado: (2004)

Bioinformatics Analysis Identifies Precision Treatment with Paclitaxel for Hepatocellular Carcinoma Patients Harboring Mutant <i>TP53</i> or Wild-Type <i>CTNNB1</i> Gene
por: Jiunn-Chang Lin, et al.
Publicado: (2021)

Inpatient phase-advance therapy for delayed sleep–wake phase disorder: a retrospective study
por: Takeshima M, et al.
Publicado: (2018)

Measuring HCC Tumor Size in MRI—The Sequence Matters!
por: Marco Armbruster, et al.
Publicado: (2021)

Hospital Frailty Risk Score Is Independently Associated with Mortality and Encephalopathy in Hospitalized Patients with Hepatocellular Carcinoma
por: Daryl Ramai, et al.
Publicado: (2021)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Anmin Huang, et al.
Publicado: (2021)

An update on subtypes of hepatocellular carcinoma: From morphology to molecular
por: Monika Vyas, et al.
Publicado: (2021)

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
por: Saleh A. Alqahtani, et al.
Publicado: (2021)

Imaging Features of Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: A Multicenter Study
por: Jun-Yi Wu, et al.
Publicado: (2021)

Contrast-enhanced Ultrasound Assessment of Treatment Response in a Patient with Multifocal Hepatocellular Carcinoma Treated with Transarterial Chemo and Radioembolization
por: Esika Savsani, Mohamed Tantawi, MD, Corinne E. Wessner, MBA, RDMS, RVT, Philip Lee, MD, Andrej Lyshchik, MD, PhD, Kevin Anton, MD, PhD, Colette M. Shaw, MD, Ji-Bin Liu, MD, John R. Eisenbrey, PhD
Publicado: (2021)

Transthyretin as a Novel Biomarker for Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients
por: Magda Ibrahim, et al.
Publicado: (2020)

Alterations in the Gut Microbiome in the Progression of Cirrhosis to Hepatocellular Carcinoma
por: Yelena Lapidot, et al.
Publicado: (2020)

Expression and Clinical Significance of MPS-1 in Hepatocellular Carcinoma
por: Jiang H, et al.
Publicado: (2021)

Hepatocarcinoma, porfiria y hemosiderosis. Una asociación no reportada en nuestro país: Caso clínico
por: WHITTLE,CAROLINA, et al.
Publicado: (2010)

Carcinoma hepatocelular variedad fibrolamelar metastásico en menores de 20 años: Reporte de 2 casos tratados con intención curativa y revisión de la literatura
por: Butte,Jean M, et al.
Publicado: (2009)

Efficacy of radiofrequency ablation versus laparoscopic liver resection for hepatocellular carcinoma in China: a comprehensive meta-analysis
por: Zhijun Li, et al.
Publicado: (2021)

Acquired perforating dermatosis in the setting of hepatocellular carcinoma
por: Reinaldo Tovo Filho, MD, PhD, et al.
Publicado: (2021)

The predictive role of preoperative serum glutamate dehydrogenase levels in microvascular invasion and hepatocellular carcinoma prognosis following liver transplantation—a single center retrospective study
por: Jinlong Gong, et al.
Publicado: (2021)

A Novel Standard for Hepatocellular Carcinoma Screening Intensity After Hepatitis C Elimination
por: Miyasaka A, et al.
Publicado: (2021)

Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration
por: Huang Y, et al.
Publicado: (2018)